Energizing Science: Exploring the Real Value of Energy Drinks with Dr. Andrew Jagim

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.com

This week on the podcast Mikki speaks to Dr Andrew Jagim about the value of energy drinks. There are literally hundreds of different choices available, and while they may seem like the domain of the sleep deprived or of the adolescent gamer, there‚Äôs more to them than just leaving you wired. They do a deep dive into the ins and outs, based on a position statement released by the international sports science and nutrition group, as to what the science says is worth purchasing, and what is best left on the shelf. They discuss the ingredients that have a real sports performance benefit, the timing of consumption in order to optimise their benefits, what athletes should look for in their ideal multi-ingredient drink, what the potential risks are (and for whom) and the appropriateness of them for an adolescent population. 

Dr. Jagim is currently the Director of Sport Medicine Research for the Mayo Clinic Health System in La Crosse, Wisconsin and an Associate Professor of Family Medicine. Dr. Jagim completed his PhD in Kinesiology with an emphasis in Exercise Physiology at Texas A&M University. Andrew is also a certified strength & conditioning specialist with distinction through the National Strength & Conditioning Association and a certified sports nutritionist through the International Society of Sports Nutrition. 
His primary research area focuses on nutritional requirements, knowledge and dietary intake of athletes and how these factors influence performance and health. Dr. Jagim also studies the physiological demands of various sports and how they pertain to injury, recovery status and performance. He also has a focused interest on the safety and efficacy of dietary supplements. This work has led to several publications in peer reviewed journals, and presentations at national conference events. 

Position statement discussed: https://pubmed.ncbi.nlm.nih.gov/36862943/